SCHEMBL17653228

SCHEMBL17653228

CCCc1nc(CCC(C)C)nc2ccc(-c3cnco3)cc12

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653204 0.92 AAK1 (0.67) AAK1
SCHEMBL17653210 0.85 AAK1 (0.63) AAK1
SCHEMBL17653232 0.84 AAK1 (0.51) AAK1
SCHEMBL17653338 0.83 AAK1 (0.66) AAK1
SCHEMBL17653143 0.83 AAK1 (0.65) AAK1
SCHEMBL17653102 0.83 AAK1 (0.65) AAK1
SCHEMBL17653113 0.83 AAK1 (0.50) AAK1
SCHEMBL17653304 0.83 AAK1 (0.65) AAK1
SCHEMBL17653255 0.82 AAK1 (0.66) AAK1
SCHEMBL17653123 0.80 AAK1 (0.54) AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed